Brief: Solara Active Pharma Sciences Approves Sale Of 100% Shareholding In Sequent Penems
March 25 (Reuters) - Solara Active Pharma Sciences Ltd
SOLA.NS :
* APPROVED SALE OF 100% SHAREHOLDING IN SEQUENT PENEMS
Source text for Eikon: ID:
Further company coverage: SOLA.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees